T

Tong Ren Tang Technologies Co Ltd
HKEX:1666

Watchlist Manager
Tong Ren Tang Technologies Co Ltd
HKEX:1666
Watchlist
Price: 4.83 HKD 1.47% Market Closed
Market Cap: 6.2B HKD
Tong Ren Tang Technologies Co Ltd
/
Income Statement
/
Operating Income

Tong Ren Tang Technologies Co Ltd
Operating Income

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

Tong Ren Tang Technologies Co Ltd
Operating Income Peer Comparison

Competitors Analysis
Latest Figures & CAGR of Competitors

Company Operating Income CAGR 3Y CAGR 5Y CAGR 10Y
T
Tong Ren Tang Technologies Co Ltd
HKEX:1666
Operating Income
¥1.1B
CAGR 3-Years
2%
CAGR 5-Years
-1%
CAGR 10-Years
N/A
H
Hansoh Pharmaceutical Group Company Ltd
HKEX:3692
Operating Income
¥5.1B
CAGR 3-Years
20%
CAGR 5-Years
13%
CAGR 10-Years
N/A
Zhangzhou Pientzehuang Pharmaceutical Co Ltd
SSE:600436
Operating Income
¥3.5B
CAGR 3-Years
10%
CAGR 5-Years
20%
CAGR 10-Years
24%
Jiangsu Hengrui Pharmaceuticals Co Ltd
SSE:600276
Operating Income
¥5.8B
CAGR 3-Years
-3%
CAGR 5-Years
3%
CAGR 10-Years
14%
Yunnan Baiyao Group Co Ltd
SZSE:000538
Operating Income
¥4B
CAGR 3-Years
2%
CAGR 5-Years
9%
CAGR 10-Years
1%
C
CSPC Innovation Pharmaceutical Co Ltd
SZSE:300765
Operating Income
¥164.1m
CAGR 3-Years
-21%
CAGR 5-Years
-12%
CAGR 10-Years
N/A

Tong Ren Tang Technologies Co Ltd
Glance View

Economic Moat
None
Market Cap
6.2B HKD
Industry
Pharmaceuticals

Tong Ren Tang Technologies Co., Ltd. engages in the production and distribution of Chinese medicine. The company is headquartered in Beijing, Beijing. The company went IPO on 2000-10-31. The Company’s subsidiaries include Beijing Tong Ren Tang Technologies (Tangshan) Co., Ltd, Beijing Tong Ren Tang Century Advertising Co., Limited and Beijing Tong Ren Tang International Natural-Pharm Co., Ltd.. Through its subsidiaries, the Company is also engaged in cultivating, purchasing and selling Chinese medicinal raw materials.

Intrinsic Value
8.52 HKD
Undervaluation 43%
Intrinsic Value
Price
T
What is Intrinsic Value?

See Also

What is Tong Ren Tang Technologies Co Ltd's Operating Income?
Operating Income
1.1B CNY

Based on the financial report for Jun 30, 2024, Tong Ren Tang Technologies Co Ltd's Operating Income amounts to 1.1B CNY.

What is Tong Ren Tang Technologies Co Ltd's Operating Income growth rate?
Operating Income CAGR 5Y
-1%

Over the last year, the Operating Income growth was -14%. The average annual Operating Income growth rates for Tong Ren Tang Technologies Co Ltd have been 2% over the past three years , -1% over the past five years .

Back to Top
ALPHA SPREAD
Follow us
Join more than 243,100+ value investors using Alpha Spread
Create a free account
or see our plans & pricing

Company

About Us Careers Pricing Affiliate Program Terms of Service Privacy Policy

Help

What is Intrinsic Value? Help Center Contact Us

Tools

Stock Screener Intrinsic Value Calculator DCF Value Calculator Discount Rate Calculator

Stocks

Most Undervalued Stocks Wide Economic Moat Stocks High Profitability Stocks High Solvency Stocks Most Popular Stocks

© 2025 Alpha Spread Limited. All Rights Reserved.

www.alphaspread.com is not operated by a broker, a dealer, or a registered investment adviser. Under no circumstances does any information posted on www.alphaspread.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute, investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. In no event shall Alpha Spread Limited be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on www.alphaspread.com, or relating to the use of, or inability to use, www.alphaspread.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance.